Insight ReportAI in Action: Redefining Drug Discovery Madhav Pitaliya, Analyst Sector Lead: Anand Kumar, Associate Director of Retail Research July 24, 2024 Reasons to ReadArtificial intelligence (AI) and generative AI are transforming industries worldwide, and the healthcare sector is no exception. Discover the applications and benefits of AI in revolutionizing drug discovery, and notable technology providers in the space. Companies mentioned in this report include: BenevolentAI, Exscientia, Insilico Medicine, Novo Nordisk, Pfizer, XtalPi Other relevant research: AI/XR, M.D.: Healthcare’s Tech-Enabled Future—Part One and Part Two Retail 2024: Top 10 Trends in US Healthcare Market Navigator: US Drugstore and Pharmacy Retailers—A Strong Focus on Healthcare Expansion in 2024 and Beyond Generative AI for US Retail Pharmacies and Healthcare: Satisfying Customers through Automation and Personalization AI Is Revolutionizing Healthcare: Four Applications, Countless Benefits Visit the Coresight Research Retail Technology Hub to explore reports, data and competitive landscapes on technology. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Shoptalk Fall 2025 Wrap-Up: Driving Retail Forward—AI, Agility, Loyalty and Leadership in Volatile TimesRedefining Global Sourcing: What a US–India Trade Deal Means for Retailers and ManufacturersThree Data Points We’re Watching This Week, Week 19: China and US Consumer Sentiment in FocusEarnings Insights 1Q25, Week 7: Dollar Stores See Growth Amid Tariff Pressures—Infographic
